Late Breaking Abstract - CPAnet Registry – An International Chronic Pulmonary Aspergillosis Registry
E. Van Braeckel (Ghent, Belgium), L. Van Acker (Ghent, Belgium), H. Salzer (Linz, Austria), D. Seidel (Cologne, Germany), O. Cornely (Cologne, Germany), M. Hoenigl (La Jolla, United States of America), A. Alastruey-Izquierdo (Madrid, Spain), C. Hennequin (Paris, France), C. Godet (Paris, France), A. Barac (Belgrade, Republic of Serbia), H. Flick (Graz, Austria), O. Munteanu (Chisinau, Republic of Moldova), C. Laursen (Odense, Denmark), J. Davidsen (Odense, Denmark)
Source: Virtual Congress 2020 – Airway infection: the microbiome and beyond
Session: Airway infection: the microbiome and beyond
Session type: Oral Presentation
Number: 4929
Disease area: Airway diseases
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
E. Van Braeckel (Ghent, Belgium), L. Van Acker (Ghent, Belgium), H. Salzer (Linz, Austria), D. Seidel (Cologne, Germany), O. Cornely (Cologne, Germany), M. Hoenigl (La Jolla, United States of America), A. Alastruey-Izquierdo (Madrid, Spain), C. Hennequin (Paris, France), C. Godet (Paris, France), A. Barac (Belgrade, Republic of Serbia), H. Flick (Graz, Austria), O. Munteanu (Chisinau, Republic of Moldova), C. Laursen (Odense, Denmark), J. Davidsen (Odense, Denmark). Late Breaking Abstract - CPAnet Registry – An International Chronic Pulmonary Aspergillosis Registry. 4929
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you:
Case Series of COVID-19 Disease in Pediatric Chronic Lung Diseases Source: Virtual Congress 2021 – Paediatric respiratory infections: chronic infection, vaccination and lung function Year: 2021
Late Breaking Abstract - Validation of the REVEAL 2.0 Risk Score with the Australian and New Zealand Pulmonary Hypertension Registry Cohort. Source: International Congress 2019 – Endpoints and risk assessment of pulmonary arterial hypertension Year: 2019
Late Breaking Abstract - Balloon Pulmonary Angioplasty for the Treatment of Non Operable Chronic Thromboembolic Pulmonary Hypertension – Initial experience of a Belgian Center Source: International Congress 2018 – Chronic thromboembolic pulmonary hypertension Year: 2018
Severe Pulmonary Hypertension Management Across Europe (PHAROS): an ERS Clinical Research Collaboration Source: Eur Respir J, 55 (5) 2001047; 10.1183/13993003.01047-2020 Year: 2020
Late Breaking Abstract - Characteristics of Patients Diagnosed with Severe Asthma at UK Specialist Centres: Variation by Ethnicity Source: International Congress 2019 – Bronchiectasis Year: 2019
European Respiratory Society Guideline on Long-term Home Non-Invasive Ventilation for Management of Chronic Obstructive Pulmonary Disease Source: Guideline 2019 Year: 2019
Is Virtual Autonomous Physiotherapist Tele-rehabilitation Program in Chronic Obstructive Pulmonary Disease equal to Hospital-Based Pulmonary Rehabilitation? Source: Virtual Congress 2020 – Digital health interventions in respiratory medicine Year: 2020
Clinical and Epidemiological Features of Lung Cancer Complicated with Pulmonary Embolism Source: International Congress 2017 – Lung cancer: clinically relevant aspects of epidemiology, co-morbidities, metastasised disease and follow-up Year: 2017
Multicenter Registry of Interstitial Lung Diseases in Brazil Source: International Congress 2019 – Immune-mediated interstitial lung diseases: from bench to bedside Year: 2019
Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease 2017 Report: GOLD Executive Summary Source: Eur Respir J , 49 (3) 1700214; DOI: 10.1183/13993003.00214-2017 Year: 2017
Update on CADSET (Chronic Airway Disease Early Stratification) Clinical Research Collaboration Source: Virtual Congress 2020 – New tools for diagnosis of obstructive diseases Year: 2020
The Disease Burden of Bronchiectasis in Korea: A National Database Study Source: International Congress 2019 – Tuberculosis epidemiology, bronchiectasis, other infections and spirometry Year: 2019
DANILDA – The First Danish National Interstitial Lung Disease Registry Source: International Congress 2019 – Interstitial lung disease registries Year: 2019
Late Breaking Abstract - Standard-of-Care Asthma Controller Regimen Reduction with Benralizumab Treatment: ANDHI In Practice Study Source: Virtual Congress 2021 – Severe asthma: evaluation using patient-reported outcome measures (PROMs) and biomarkers, comorbidities and treatments Year: 2021
Risk Factors for Mortality in Patients with Idiopathic Pulmonary Fibrosis Followed at Intensive Care Unit due to Acute Respiratory Failure Source: International Congress 2018 – What is new in idiopathic interstitial pneumonias? Year: 2018
Impact on Adherence to the 2012 Evaluation and Management of Pediatric Community Acquired Pneumonia Philippine Academy of Pediatric Pulmonologist (PAPP) Update Source: International Congress 2018 – Clinical problems in paediatric pulmonology Year: 2018
Modes of Disease Progression in Different Forms of Interstitial Lung Disease with Usual Interstitial Pneumonia Histology in Patients with Idiopathic and Non-idiopathic Etiologies - A Single Center Experience Source: International Congress 2019 – Immune-mediated interstitial lung diseases: from bench to bedside Year: 2019
Cardiovascular Outcomes in Children who had Chronic Lung Disease of Prematurity in Infancy Source: International Congress 2019 – Innovative ways to diagnose and monitor children with lung diseases and sleep-disordered breathing Year: 2019